- A study by Apple in partnership with Johnson & Johnson and Heartline aims to provide data to prove that the Apple Watch can help detect early signs of a stroke.
- American citizens aged 65 or over will be eligible to take part in this study.
- This study will be conducted over a period of three years and requires users to give data to their Medicare claims.
As per a new report, the Apple Watch could be saving millions of lives in the future thanks to a new feature that the company is working in tandem with Johnson & Johnson and the Heartline Study. These firms will reportedly work with Apple to detect early signs of atrial fibrillation. This could be immensely beneficial in detecting strokes early, thus saving even more lives than it currently does.
The Apple Watch can already notify users when signs of arrhythmia start showing on the ECG app. It is said that atrial fibrillation will work quite similarly to how arrhythmia is detected on the Apple Watch.
The Heartline Study is conducting trials for people aged 65 and older as part of research on atrial fibrillation. The company is willing to loan Apple Watch units to members of this study, while the minimum requirements to be a part of this study are just an iPhone 6s or newer iPhone.
Here are some of the terms for this new study by Heartline:
- Live in the US
- 65 years of age or older
- Have original Medicare
- Use an iPhone 6s or older
- Agree to provide Medicare claims data access
This study will be conducted over a period of three years, including one full year of data collection and two years of engagement. It is said that the participants will be split into two groups, one that will use the Heartline Study app on their iPhones, and another group which will use the ECG app on their Apple Watch along with the irregular rhythm notification feature.